Long-Term Liabilities: The sum of all non-current liabilities.
Aardvark Therapeutics, Inc. (AARD) had Long-Term Liabilities of $0.24M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-14.37M |
|
-- |
|
-- |
|
$15.85M |
|
$-15.85M |
|
$1.48M |
|
$-14.37M |
|
$-14.36M |
|
$-14.37M |
|
$-14.37M |
|
$-14.37M |
|
$-14.36M |
|
$-15.85M |
|
$-16.46M |
|
21.69M |
|
21.69M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$144.77M |
|
-- |
|
$2.71M |
|
$147.47M |
|
$10.31M |
|
-- |
|
|
Long-Term Liabilities |
$0.24M |
$10.55M |
|
$136.93M |
|
$136.93M |
|
$136.93M |
|
21.69M |
|
| Cash Flow Statement Financials | |
$-21.23M |
|
$-103.22M |
|
$88.80M |
|
$61.64M |
|
$26.00M |
|
$-35.64M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.49% |
|
-10.49% |
|
-9.74% |
|
-10.49% |
|
$6.31 |
|
$-0.98 |
|
$-0.98 |
|